WHO ICTRP trial
The effect of 0,9% SodiumChloride on the kidney function, vaso-active hormones…
EUCTR2014-004742-10-DK · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2014-004742-10-DK |
|---|---|
| Public title | The effect of 0,9% SodiumChloride on the kidney function, vaso-active hormones, biomarkers and glycocalyx in patients operated on for primary hiparthrosis. |
| Scientific title | The effect of 0,9% NaCl on the kidney function, vasoactive hormones, biomarkers and glycosaminglycanes in plasma in patients operated on for primary hiparthrosis. - 0,9% NaCl effect on kidney function and glycocalyx in patients operated on for primary hiparthrosis |
| Primary sponsor | Department of medical Research, Regional Hospital Holstebro |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Denmark |
| Conditions | Kidney function during operation MedDRA version: 18.0 Level: LLT Classification code 10023422 Term: Kidney function abnormal System Organ Class: 100000004857 ;Therapeutic area: Body processes [G] - Physiological processes [G07] |
| Interventions | Trade Name: Isoton NaCl Pharmaceutical Form: Infusion Pharmaceutical form of the placebo: Infusion Route of administration of the placebo: Intravenous use Trade Name: Plasmalyte Product Name: Plasmalyte Product Code: B05BB01 Pharmaceutical… |
| Registration date | Dec 11, 2014 |
| Secondary IDs | NPE-01-2014 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: